SUPRAN BRYAN

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return 30% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
SUPRAN BRYAN's trades of Alnylam Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
GB Haleon PLC (HLN)
Transaction date
Purchase
Price
92.47
Quantity 73,930
Value US$3,424,722
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-06 2026-10-02
S Sale
25,746 -10.2%
264.69
US$58,201 		25,746 -10.2% 264.69 US$58,201
2026-10-02 2026-10-02
PrS Proposed sale
29,670
150.87
US$1,868,728 		29,670 150.87 US$1,868,728
2022-08-02 2022-08-01
GB Haleon PLC (HLN)
B Purchase
73,930
92.47
US$3,424,722 		73,930 92.47 US$3,424,722